| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |